DavidsonBL, SteinCS, HethJA, et al.Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A, 2000; 97:3428.
2.
LiT, DavidsonBL. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc Natl Acad Sci U S A, 1995; 92:7700.
3.
BrooksAI, SteinCS, HughesSM, et al.Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci U S A, 2002; 99:6216.
4.
XiaH, MaoQ, PaulsonHL, et al.siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol, 2002; 20:1006–1010.
5.
HarperSQ, StaberPD, HeX, et al.RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci U S A, 2005; 102:5820.
6.
XiaH, MaoQ, EliasonSL, et al.RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med, 2004; 10:816–820.
7.
MonteysAM, HundleyAA, RanumPT, et al.Regulated control of gene therapies by drug-induced splicing. Nature, 2021; 596:291–295.
